How Rifampin Affects Famciclovir
Rifampin, a potent inducer of cytochrome P450 enzymes (primarily CYP3A4 and CYP2C9), reduces famciclovir's effectiveness by accelerating its metabolism. Famciclovir is a prodrug converted to penciclovir, its active antiviral form, via hepatic enzymes including ALDH and CYP3A4. Rifampin induces these enzymes, lowering penciclovir's plasma concentrations by about 70-80% after repeated dosing, which decreases antiviral activity against herpes viruses like HSV and VZV.[1][2]
Mechanism of the Interaction
Rifampin upregulates CYP3A4, which metabolizes famciclovir to its intermediate 6-deoxypenciclovir, and enhances glucuronidation. This leads to faster clearance and reduced bioavailability. Studies show penciclovir AUC drops significantly (e.g., 75% reduction with rifampin 600 mg daily), shortening the drug's therapeutic duration.[1][3]
Clinical Evidence
- In healthy volunteers, coadministration cut penciclovir Cmax by 65% and AUC by 74%.[1]
- No direct outcome trials exist for herpes infections, but the pharmacokinetic drop suggests suboptimal viral suppression, similar to acyclovir's reduced efficacy with rifampin.[2]
Guidelines (e.g., FDA labels) warn against concurrent use, recommending alternatives or dose adjustments without specific guidance due to limited data.[4]
Management and Recommendations
Avoid combining rifampin with famciclovir if possible. Switch to non-CYP dependent antivirals like IV acyclovir (less affected) or monitor closely with higher famciclovir doses (not validated). Rifampin's induction persists 2-3 weeks post-discontinuation, requiring spacing.[1][2]
Related Drug Interactions
| Drug | Effect on Famciclovir | Notes |
|------|-----------------------|-------|
| Rifampin | Major ↓ (70-80%) | Strongest inducer[1] |
| Rifabutin | Moderate ↓ (50%) | Weaker alternative[2] |
| Probenecid | ↑ (prolongs penciclovir) | Inhibits renal excretion[3] |
| Valacyclovir | No significant interaction | Different metabolism[4] |
When to Worry Most
Highest risk in treating active herpes zoster or genital herpes outbreaks while on TB therapy. Pregnant patients or immunocompromised individuals face greater viral breakthrough potential.[2]
[1]: FDA Famciclovir Label
[2]: Drugs.com Interaction Checker
[3]: Fichtenbaum CJ et al. Clin Pharmacol Ther. 2002;72(4):382-92. PubMed
[4]: Lexicomp Interaction Monograph. UpToDate 2023.